Pharmather Holdings Ltd
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia… Read more
Pharmather Holdings Ltd (PHRRF) - Total Liabilities
Latest total liabilities as of November 2025: $443.88K USD
Based on the latest financial reports, Pharmather Holdings Ltd (PHRRF) has total liabilities worth $443.88K USD as of November 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pharmather Holdings Ltd - Total Liabilities Trend (2021–2024)
This chart illustrates how Pharmather Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pharmather Holdings Ltd Competitors by Total Liabilities
The table below lists competitors of Pharmather Holdings Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €767.72 Million |
|
Niobay Metals Inc
OTCQB:NBYCF
|
USA | $187.11K |
|
ULTA SALON C&F
MU:34U
|
Germany | €3.39 Billion |
|
Siab Holdings Bhd
KLSE:0241
|
Malaysia | RM636.07 Million |
|
Bullfrog AI Holdings, Inc. Common Stock
NASDAQ:BFRG
|
USA | $758.70K |
|
Olive Resource Capital Inc
V:OC
|
Canada | CA$773.00K |
|
Qwamplify SA
PA:ALQWA
|
France | €30.06 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Pharmather Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmather Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmather Holdings Ltd (2021–2024)
The table below shows the annual total liabilities of Pharmather Holdings Ltd from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-05-31 | $252.90K | -71.66% |
| 2023-05-31 | $892.48K | +170.19% |
| 2022-05-31 | $330.32K | -8.51% |
| 2021-05-31 | $361.06K | -- |